Flumazenil Injection 0.5 mg Per 5 mL (1.0 mg/mL) Multiple Dose Vials 10/Box by Fresenius Kabi (RX)

Flumazenil Injection is used to reverse the effects of benzodiazepines, particularly during cases of overdose or in situations requiring rapid recovery from sedation. As a benzodiazepine antagonist, it swiftly counteracts sedation and respiratory depression caused by these medications. This injection is crucial in emergency and critical care settings to restore consciousness and improve breathing in patients affected by benzodiazepine use. Administered by healthcare professionals, it enhances patient safety during medical procedures and overdose management.

Fresenius Kabi presents Flumazenil for Injection, a critical antidote designed for rapid reversal of benzodiazepine sedation and overdose. With a formulation of 0.5 mg per 5 mL (1.0 mg/mL), this injectable solution comes in multiple dose vials, providing healthcare professionals with precise control over administration. Packaged in boxes containing 10 vials, this product ensures ample supply for medical settings where benzodiazepine influence must be promptly addressed, enhancing patient safety and recovery.

Details and Features:

Concentration and Formulation: Each 5 mL vial contains 0.5 mg of Flumazenil, giving a concentration of 1.0 mg/mL, to facilitate titration based on individual patient needs.
Packaging: Supplied in multiple-dose vials, arranged in boxes of 10, to accommodate both emergency responses and sedation reversal protocols in clinical practice.
Administration Route: Intended for intravenous use, providing immediate onset of action critical for timely intervention in cases of benzodiazepine overdose or sedation reversal.
Indications: Quickly and effectively reverses the sedative effects of benzodiazepines used in anesthesia or during medical procedures, and treats benzodiazepine overdoses in emergent situations.

Mechanism of Action:

Flumazenil acts as a benzodiazepine receptor antagonist. By competitively inhibiting benzodiazepine binding on the gamma-aminobutyric acid (GABA) receptor complex, it blocks the depressant effects on the central nervous system. This blockade effectively reverses sedation, amnesia, and respiratory depression induced by benzodiazepines, restoring the patient’s baseline level of consciousness and respiratory function.

Warnings:

• Seizure Risk: Flumazenil administration in certain patient populations, particularly those with benzodiazepine dependence or concurrent tricyclic antidepressant overdose, can precipitate seizures. Caution is advised with gradual and monitored dosage adjustments.
  
• Re-Sedation Danger: Recurrent sedation may occur due to flumazenil’s shorter half-life compared to most benzodiazepines. Continuous monitoring post-administration is necessary until the resedative risk has passed.
  
• Hypersensitivity Reaction: Consider avoiding use in patients with a history of hypersensitivity to flumazenil or other benzodiazepine antagonists.
  Concomitant Drug Use: Caution the use in patients with mixed-drug overdoses, as flumazenil is specific to benzodiazepines and does not reverse effects of non-benzodiazepine CNS depressants.

Side Effects:

• Neurological: Dizziness, headache, or agitation following administration.
  
• Gastrointestinal: Nausea or vomiting post-injection.
  
• Cardiovascular: Potential for tachycardia or hypertension in response to sudden CNS activity changes.
  
• Injection Site Reactions: Possible localized pain or discomfort at the site of administration.

Clinical Considerations:

• Patient Monitoring: Ensure continuous observation for signs of seizure activity or resedation, particularly in patients with histories of seizure disorders or chronic benzodiazepine usage.
  
• Infusion Rates and Protocols: Administer flumazenil slowly, titrating doses incrementally to minimize adverse reactions while achieving therapeutic effects.
  
• Comprehensive Assessment: A detailed evaluation of any potential risks related to benzodiazepine withdrawal, such as substance dependence or co-ingestant toxicity, is crucial prior to administration.

Flumazenil for Injection by Fresenius Kabi is an essential medication for healthcare professionals in emergency or perioperative settings, enabling them to safely counteract benzodiazepine effects and ensure optimal patient care. Detailed prescribing information should be consulted to ensure comprehensive understanding and implementation of treatment protocols.